Annual report pursuant to Section 13 and 15(d)

Share-Based Compensation - Restricted Stock Units (Details)

v3.24.3
Share-Based Compensation - Restricted Stock Units (Details) - Restricted Stock Units - USD ($)
 12 Months Ended
Jan. 26, 2024
Jun. 26, 2023
Jun. 22, 2023
Mar. 31, 2023
Jan. 20, 2023
Nov. 11, 2022
Nov. 10, 2022
Aug. 29, 2022
Jun. 30, 2024
Share-Based Compensation                  
Number of shares issued 78,800                
Market value per share $ 1.18                
Vesting period 1 year                
Grant date fair value $ 93,000                
Unrecognized compensation, non-vested awards                 $ 35,000
Cost recognition period, non-vested options                 7 months 6 days
Employees                  
Share-Based Compensation                  
Number of shares issued               347  
Market value per share               $ 141.20  
Vesting period               4 years  
Grant date fair value               $ 49,000  
Employees | 2020 Omnibus Equity Incentive Plan                  
Share-Based Compensation                  
Number of shares issued       11,250          
Vesting period       12 months          
Grant date fair value       $ 468,000          
Employees | Mr. Thomas Isett, former Chief Executive Officer                  
Share-Based Compensation                  
Number of shares issued             10,000    
Vesting period             3 years    
Grant date fair value             $ 296,000    
Employees | Mr. Robert Lutz, former Chief Financial and Business Officer                  
Share-Based Compensation                  
Number of shares issued           5,002      
Grant date fair value           $ 175,100      
Employees | Dr. Martin Brenner, former Chief Scientific Officer                  
Share-Based Compensation                  
Number of shares issued           4,767      
Grant date fair value           $ 167,000      
Employees | Dr. Martin Brenner, former Interim Chief Executive Officer                  
Share-Based Compensation                  
Number of shares issued         6,500        
Vesting period         12 months        
Grant date fair value         $ 91,000        
Number of shares terminated     3,792            
Employees | Dr. Martin Brenner, Chief Executive Officer                  
Share-Based Compensation                  
Number of shares issued   3,791              
Vesting period   7 months              
Grant date fair value   $ 52,000              
Employees | Dr. Martin Brenner, Chief Executive Officer | 2020 Omnibus Equity Incentive Plan                  
Share-Based Compensation                  
Number of shares issued       2,500          
Employees | Mr. Felipe Duran, Chief Financial Officer | 2020 Omnibus Equity Incentive Plan                  
Share-Based Compensation                  
Number of shares issued       1,875